Centiva Capital’s SBC Medical Group SBC Stock Holding History

Centiva Capital’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-97,000	Closed	-$1.04M	–	2349
2023 Q4	$1.04M	Hold	97,000	–	–	0.02%	603
2023 Q3	$1.03M	Sell	97,000 -28,000	-22%	-$295K	0.02%	625
2023 Q2	$1.29M	Hold	125,000	–	–	0.03%	504
2023 Q1	$1.3M	Buy	+125,000	New	+$1.29M	0.03%	524

Other funds holding SBC

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TCM

Tuttle Capital Management Riverside, Connecticut $148M AUM 64.07% 1-Year Est. Return

Centiva Capital's SBC Position: Q1 2024 in Review

Centiva Capital sold out of SBC Medical Group (SBC) in Q1 2024, closing a stake of 97,000 shares — an estimated $1.04M sold.

Centiva Capital first reported a position in SBC in Q1 2023 and held it in 4 quarters. The position peaked at $1.3M in Q1 2023. 5 funds tracked by Wall St. Rank hold SBC as of Q1 2024.

Centiva Capital reported no remaining SBC Medical Group position as of Q1 2024 after selling out during the quarter.
Centiva Capital sold 97,000 SBC Medical Group shares in Q1 2024, an estimated $1.04M.
Centiva Capital first reported a position in SBC Medical Group in Q1 2023 and held it in 4 quarters.
Centiva Capital's SBC Medical Group position peaked at $1.3M in Q1 2023.
5 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2024.

Based on Centiva Capital's 13F filing for Q1 2024, filed 15 May 2024.